Debunking Covid & Conspirituality Misinformation

Debunking Covid & Conspirituality Misinformation

693 bookmarks
Newest
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the UK variant of concern B.1.1.7), admissions to hospital, and deaths. Design Test negative case-control study. Setting Community testing for covid-19 in England. Participants 156 930 adults aged 70 years and older who reported symptoms of covid-19 between 8 December 2020 and 19 February 2021 and were successfully linked to vaccination data in the National Immunisation Management System. Interventions Vaccination with BNT162b2 or ChAdOx1-S. Main outcome measures Primary outcomes were polymerase chain reaction confirmed symptomatic SARS-CoV-2 infections, admissions to hospital for covid-19, and deaths with covid-19. Results Participants aged 80 years and older vaccinated with BNT162b2 before 4 January 2021 had a higher odds of testing positive for covid-19 in the first nine days after vaccination (odds ratio up to 1.48, 95% confidence interval 1.23 to 1.77), indicating that those initially targeted had a higher underlying risk of infection. Vaccine effectiveness was therefore compared with the baseline post-vaccination period. Vaccine effects were noted 10 to 13 days after vaccination, reaching a vaccine effectiveness of 70% (95% confidence interval 59% to 78%), then plateauing. From 14 days after the second dose a vaccination effectiveness of 89% (85% to 93%) was found compared with the increased baseline risk. Participants aged 70 years and older vaccinated from 4 January (when ChAdOx1-S delivery commenced) had a similar underlying risk of covid-19 to unvaccinated individuals. With BNT162b2, vaccine effectiveness reached 61% (51% to 69%) from 28 to 34 days after vaccination, then plateaued. With ChAdOx1-S, effects were seen from 14 to 20 days after vaccination, reaching an effectiveness of 60% (41% to 73%) from 28 to 34 days, increasing to 73% (27% to 90%) from day 35 onwards. On top of the protection against symptomatic disease, a further 43% (33% to 52%) reduced risk of emergency hospital admission and 51% (37% to 62%) reduced risk of death was observed in those who had received one dose of BNT162b2. Participants who had received one dose of ChAdOx1-S had a further 37% (3% to 59%) reduced risk of emergency hospital admission. Follow-up was insufficient to assess the effect of ChAdOx1-S on mortality. Combined with the effect against symptomatic disease, a single dose of either vaccine was about 80% effective at preventing admission to hospital with covid-19 and a single dose of BNT162b2 was 85% effective at preventing death with covid-19. Conclusion Vaccination with either one dose of BNT162b2 or ChAdOx1-S was associated with a significant reduction in symptomatic covid-19 in older adults, and with further protection against severe disease. Both vaccines showed similar effects. Protection was maintained for the duration of follow-up (6 weeks). A second dose of BNT162b2 was associated with further protection against symptomatic disease. A clear effect of the vaccines against the B.1.1.7 variant was found.
·bmj.com·
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Unverified reports of vaccine side effects in VAERS aren’t the smoking guns portrayed by right-wing media outlets – they can offer insight into vaccine hesitancy
Unverified reports of vaccine side effects in VAERS aren’t the smoking guns portrayed by right-wing media outlets – they can offer insight into vaccine hesitancy
Anti-vaccine activists are using the side effect reporting system to spread fear and misinformation about the COVID-19 vaccines. But the database could also be used as a gauge for public concerns.
·theconversation.com·
Unverified reports of vaccine side effects in VAERS aren’t the smoking guns portrayed by right-wing media outlets – they can offer insight into vaccine hesitancy
The Red/Blue Divide in COVID-19 Vaccination Rates Continues: An Update | KFF
The Red/Blue Divide in COVID-19 Vaccination Rates Continues: An Update | KFF
This analysis is an update to a previous analysis conducted in September 2021. Using county-level data, we analyzed trends in COVID-19 vaccination rates in counties that voted for President Trump in the 2020 election compared to counties that voted for President Biden. We find higher vaccination rates for counties that voted for Biden. However, rates among those fully vaccinated that have received a booster are similar between the two groups.
·kff.org·
The Red/Blue Divide in COVID-19 Vaccination Rates Continues: An Update | KFF
Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries
Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries
Objective To estimate the direct and indirect effects of the covid-19 pandemic on mortality in 2020 in 29 high income countries with reliable and complete age and sex disaggregated mortality data. Design Time series study of high income countries. Setting Austria, Belgium, Czech Republic, Denmark, England and Wales, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Latvia, Lithuania, the Netherlands, New Zealand, Northern Ireland, Norway, Poland, Portugal, Scotland, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, and United States. Participants Mortality data from the Short-term Mortality Fluctuations data series of the Human Mortality Database for 2016-20, harmonised and disaggregated by age and sex. Interventions Covid-19 pandemic and associated policy measures. Main outcome measures Weekly excess deaths (observed deaths versus expected deaths predicted by model) in 2020, by sex and age (0-14, 15-64, 65-74, 75-84, and ≥85 years), estimated using an over-dispersed Poisson regression model that accounts for temporal trends and seasonal variability in mortality. Results An estimated 979 000 (95% confidence interval 954 000 to 1 001 000) excess deaths occurred in 2020 in the 29 high income countries analysed. All countries had excess deaths in 2020, except New Zealand, Norway, and Denmark. The five countries with the highest absolute number of excess deaths were the US (458 000, 454 000 to 461 000), Italy (89 100, 87 500 to 90 700), England and Wales (85 400, 83 900 to 86 800), Spain (84 100, 82 800 to 85 300), and Poland (60 100, 58 800 to 61 300). New Zealand had lower overall mortality than expected (−2500, −2900 to −2100). In many countries, the estimated number of excess deaths substantially exceeded the number of reported deaths from covid-19. The highest excess death rates (per 100 000) in men were in Lithuania (285, 259 to 311), Poland (191, 184 to 197), Spain (179, 174 to 184), Hungary (174, 161 to 188), and Italy (168, 163 to 173); the highest rates in women were in Lithuania (210, 185 to 234), Spain (180, 175 to 185), Hungary (169, 156 to 182), Slovenia (158, 132 to 184), and Belgium (151, 141 to 162). Little evidence was found of subsequent compensatory reductions following excess mortality. Conclusion Approximately one million excess deaths occurred in 2020 in these 29 high income countries. Age standardised excess death rates were higher in men than women in almost all countries. Excess deaths substantially exceeded reported deaths from covid-19 in many countries, indicating that determining the full impact of the pandemic on mortality requires assessment of excess deaths. Many countries had lower deaths than expected in children 15 years. Sex inequality in mortality widened further in most countries in 2020.
·bmj.com·
Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries
With Trump gone, QAnon groups focus fury on attacking coronavirus vaccines
With Trump gone, QAnon groups focus fury on attacking coronavirus vaccines
Conspiracy theories about covid and vaccines once ran rampant on the likes of Facebook, Twitter and YouTube. But months of purges of accounts that trafficked heavily in misinformation - especially after the baseless QAnon ideology helped fuel the Jan. 6 siege on the U.S. Capitol - have driven adherents to the less visible but still virulent world of private groups on encrypted chat apps such as Telegram. Some groups have hundreds of thousands of users.
·washingtonpost.com·
With Trump gone, QAnon groups focus fury on attacking coronavirus vaccines
The Wellness Grift of JP Sears
The Wellness Grift of JP Sears
JP Sears is certainly not the only one moving Left or Right—politics infects everything these days. Where he landed is exactly the place he’s criticized for years: exploiting the wellness grift.
·conspirituality.net·
The Wellness Grift of JP Sears
Is the Covid 'lab-leak' theory incorrect? What new study reveals
Is the Covid 'lab-leak' theory incorrect? What new study reveals
A study by the University of Edinburgh suggests Covid-19 did not originate in China’s Wuhan but evolved naturally in the bat population in northern Laos and China’s Yunnan province. The study, now published in the peer-reviewed journal Cell, challenges the ’lab-leak’ theory championed by US President Donald Trump. Here’s what it says
·firstpost.com·
Is the Covid 'lab-leak' theory incorrect? What new study reveals
It's Not News, Nor 'Scandalous,' That Pfizer Trial Didn't Test Transmission - FactCheck.org
It's Not News, Nor 'Scandalous,' That Pfizer Trial Didn't Test Transmission - FactCheck.org
The COVID-19 vaccine clinical trials were designed to study the vaccine’s safety and efficacy in preventing symptomatic disease, not transmission. But online publications now misleadingly present the fact that the Pfizer/BioNTech vaccine was not tested for transmission as a “shocking admission” and proof that the company and the government lied.
·factcheck.org·
It's Not News, Nor 'Scandalous,' That Pfizer Trial Didn't Test Transmission - FactCheck.org